FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
Public ClinicalTrials.gov record NCT05614739. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
FORAGER-1: A Phase 1, Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Locally Advanced or Metastatic Solid Tumors Including Urothelial Cancer With FGFR3 Alterations
Study identification
- NCT ID
- NCT05614739
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 535 participants
Conditions and interventions
Interventions
- LOXO-435 Drug
- Pembrolizumab Drug
- enfortumab vedotin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 11, 2023
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
- Last update posted
- Apr 19, 2026
2023 – 2027
United States locations
- U.S. sites
- 42
- U.S. states
- 22
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona - Cancer Center | Tucson | Arizona | 85719 | Recruiting |
| City of Hope | Duarte | California | 91010 | Recruiting |
| University of California, Los Angeles (UCLA) - Division of Hematology-Oncology | Los Angeles | California | 90095 | Recruiting |
| University of California - Irvine | Orange | California | 92868 | Recruiting |
| University of California (UC) Davis Comprehensive Cancer Center | Sacramento | California | 95817 | Recruiting |
| Stanford Cancer Center | Stanford | California | 94305 | Recruiting |
| Advent Health | Orlando | Florida | 32804 | Recruiting |
| Emory University Hospital | Atlanta | Georgia | 30322 | Recruiting |
| The University of Chicago Medical Center (UCMC) | Chicago | Illinois | 60637 | Recruiting |
| Indiana University (IU) Melvin and Bren Simon Cancer Center | Indianapolis | Indiana | 46202 | Recruiting |
| Mary Bird Perkins Cancer Center | Baton Rouge | Louisiana | 70809 | Recruiting |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | Recruiting |
| Johns Hopkins Kimmel Cancer Center | Baltimore | Maryland | 21231-2410 | Recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Recruiting |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | Recruiting |
| Washington University in St. Louis | St Louis | Missouri | 63108 | Recruiting |
| New York University (NYU) | New York | New York | 10016 | Recruiting |
| Weill Cornell Medicine | New York | New York | 10021 | Not yet recruiting |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | Recruiting |
| Columbia University | New York | New York | 10032 | Recruiting |
| David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Recruiting |
| University of Rochester - Wilmot Cancer Institute | Rochester | New York | 14642 | Recruiting |
| Montefiore Medical Center | The Bronx | New York | 10467 | Recruiting |
| University of North Carolina (UNC) - Chapel Hill | Chapel Hill | North Carolina | 27599 | Recruiting |
| University of Cincinnati Medical Center (UCMC) | Cincinnati | Ohio | 45267 | Recruiting |
| The Ohio State University (OSU) | Columbus | Ohio | 43210 | Recruiting |
| University of Oklahoma - Health Sciences Center | Oklahoma City | Oklahoma | 73104 | Recruiting |
| Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute | Lancaster | Pennsylvania | 17601 | Recruiting |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | Recruiting |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | Recruiting |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | Recruiting |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | Recruiting |
| Sarah Cannon and HCA Research Institute | Nashville | Tennessee | 37203 | Recruiting |
| Tennessee Oncology | Nashville | Tennessee | 37203 | Recruiting |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212 | Recruiting |
| University of Texas Southwestern | Dallas | Texas | 75244 | Recruiting |
| Texas Oncology, P.A | Dallas | Texas | 75251 | Recruiting |
| MD Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| University of Utah | Salt Lake City | Utah | 84132 | Recruiting |
| University of Vermont Medical Center | Burlington | Vermont | 05401 | Recruiting |
| Inova Schar Cancer Institute | Falls Church | Virginia | 22042 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05614739, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05614739 live on ClinicalTrials.gov.